IBRN
IBRN
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 AXSM | Axsome Therapeutics, Inc. | 4.95% | 1.14K | $264.96K |
 ALKS | Alkermes plc | 4.81% | 6.45K | $257.45K |
 ARWR | Arrowhead Pharmaceuticals, Inc. | 4.56% | 3.09K | $244.11K |
 XENE | Xenon Pharmaceuticals Inc. | 4.53% | 4.42K | $242.12K |
 NBIX | Neurocrine Biosciences, Inc. | 4.23% | 1.45K | $226.45K |
 ARGX | argenx SE | 4.03% | 257 | $215.49K |
 PRAX | Praxis Precision Medicines, Inc. | 3.92% | 594 | $209.46K |
 PTCT | PTC Therapeutics, Inc. | 3.90% | 2.94K | $208.74K |
 CNTA | Centessa Pharmaceuticals plc | 3.86% | 5.19K | $206.45K |
 SRRK | Scholar Rock Holding Corporation | 3.80% | 4.08K | $203.02K |
 BIIB | Biogen Inc. | 3.69% | 1.00K | $197.18K |
 CPRX | Catalyst Pharmaceuticals, Inc. | 3.54% | 6.05K | $189.24K |
 DNTH | Dianthus Therapeutics, Inc. | 3.39% | 2.00K | $181.54K |
 ACAD | ACADIA Pharmaceuticals Inc. | 3.37% | 8.33K | $180.13K |
 DNLI | Denali Therapeutics Inc. | 3.06% | 7.80K | $163.41K |
 EWTX | Edgewise Therapeutics, Inc. | 2.64% | 4.23K | $140.93K |
 SUPN | Supernus Pharmaceuticals, Inc. | 2.63% | 3.00K | $140.55K |
 DYN | Dyne Therapeutics, Inc. | 2.42% | 6.97K | $129.29K |
 AXGN | AxoGen, Inc. | 2.12% | 2.80K | $113.18K |
 SRPT | Sarepta Therapeutics, Inc. | 1.77% | 5.48K | $94.80K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
Canada
Netherlands
United Kingdom
Sweden
South Korea
Denmark
Switzerland
China
Australia
Japan
France
Israel
ItalySECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland Canada Netherlands United Kingdom Sweden South Korea Denmark Switzerland China Australia Japan France Israel ItalyHoldings (Top 20)
AXSM
Axsome Therapeutics, Inc.
ALKS
Alkermes plc
ARWR
Arrowhead Pharmaceuticals, Inc.
XENE
Xenon Pharmaceuticals Inc.
NBIX
Neurocrine Biosciences, Inc.
ARGX
argenx SE
PRAX
Praxis Precision Medicines, Inc.
PTCT
PTC Therapeutics, Inc.
CNTA
Centessa Pharmaceuticals plc
SRRK
Scholar Rock Holding Corporation
BIIB
Biogen Inc.
CPRX
Catalyst Pharmaceuticals, Inc.
DNTH
Dianthus Therapeutics, Inc.
ACAD
ACADIA Pharmaceuticals Inc.
DNLI
Denali Therapeutics Inc.
EWTX
Edgewise Therapeutics, Inc.
SUPN
Supernus Pharmaceuticals, Inc.
DYN
Dyne Therapeutics, Inc.
AXGN
AxoGen, Inc.
SRPT
Sarepta Therapeutics, Inc.